Poland· PL-100351274
Dexamytrex
A dexamethason mit antiinfektiva product containing gentamicini sulfas + dexamethasoni natrii phosphas, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Dexamethason mit antiinfektiva is registered in 11 of 19 countries.
Countries holding a registration under ATC S01CA01 (dexamethason mit antiinfektiva), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Dexamethason mit antiinfektiva · ATC S01CA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Gentamicini sulfas + Dexamethasoni natrii phosphas
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- S01CA01
- ATC class
- Dexamethason mit Antiinfektiva
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991233112
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dexamethason mit antiinfektiva in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Dexagenta-Pos
- Belgium · Dexagenta-Pos
- Cyprus · Dexamytrex
- Czechia · Gentadex
- Germany · Dexa-Gentamicin
- Greece · Dexamytrex, Gentadex
- Luxembourg · Dexagenta-Pos
- Malta · Dexa-Gentamicin
- Netherlands · Dexagenta-Pos, Dexamytrex Ophtiole
- Portugal · Dexamytrex Ophtiole
- Slovakia · Dexa-Gentamicin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/debffd9d-a0f4-4f54-9c2b-125d7b974468 GET /v1/drugs/debffd9d-a0f4-4f54-9c2b-125d7b974468?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do oczu, roztwór",
"source": "urpl",
"strength": "(5 mg + 1 mg)/ml",
"packaging": "05909991233112 ¦ Rp ¦ 110217\n1 butelka 5 ml",
"substance": "Gentamicini sulfas 5 mg + Dexamethasoni natrii phosphas 1 mg",
"common_name": "Gentamicini sulfas + Dexamethasoni natrii phosphas",
"pl_product_id": "100351274",
"pozwolenie_nr": "530/15",
"auth_procedure": "IR",
"authorisation_validity": "2025-08-06"
}See everything about dexamethason mit antiinfektiva.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.